497 related articles for article (PubMed ID: 12180739)
1. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Iyama K; Shono E; Naito M; Kikuchi M
J Rheumatol; 2002 Aug; 29(8):1746-53. PubMed ID: 12180739
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
3. Histochemical localization of calcium with potassium pyroantimonate in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
Ohira T; Ishikawa K
Clin Orthop Relat Res; 1991 Mar; (264):286-94. PubMed ID: 1705190
[TBL] [Abstract][Full Text] [Related]
4. Histologic localization of lipid in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
Ohira T; Ishikawa K; Masuda I; Yokoyama M; Honda I
Arthritis Rheum; 1988 Aug; 31(8):1057-62. PubMed ID: 2457374
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.
Uzuki M; Sawai T; Ryan LM; Rosenthal AK; Masuda I
J Rheumatol; 2014 Jan; 41(1):65-74. PubMed ID: 24293574
[TBL] [Abstract][Full Text] [Related]
6. A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease.
Masuda I; Ishikawa K; Usuku G
Clin Orthop Relat Res; 1991 Feb; (263):272-87. PubMed ID: 1993383
[TBL] [Abstract][Full Text] [Related]
7. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Saeki K; Zhang J; Shono E; Naito M; Kikuchi M
J Rheumatol; 2003 May; 30(5):1032-5. PubMed ID: 12734902
[TBL] [Abstract][Full Text] [Related]
8. [Calcium pyrophosphate deposits--a chameleon].
Beyeler Ch
Ther Umsch; 2002 Oct; 59(10):523-8. PubMed ID: 12428437
[TBL] [Abstract][Full Text] [Related]
9. Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilage.
Nguyen C; Bazin D; Daudon M; Chatron-Colliet A; Hannouche D; Bianchi A; Côme D; So A; Busso N; Busso N; Lioté F; Ea HK
Arthritis Res Ther; 2013; 15(5):R103. PubMed ID: 24004678
[TBL] [Abstract][Full Text] [Related]
10. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist.
Johnson K; Farley D; Hu SI; Terkeltaub R
Arthritis Rheum; 2003 May; 48(5):1302-14. PubMed ID: 12746903
[TBL] [Abstract][Full Text] [Related]
11. Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging.
Masuda I; Iyama KI; Halligan BD; Barbieri JT; Haas AL; McCarty DJ; Ryan LM
J Bone Miner Res; 2001 May; 16(5):868-75. PubMed ID: 11341331
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed.
Frediani B; Filippou G; Falsetti P; Lorenzini S; Baldi F; Acciai C; Siagkri C; Marotto D; Galeazzi M; Marcolongo R
Ann Rheum Dis; 2005 Apr; 64(4):638-40. PubMed ID: 15769921
[TBL] [Abstract][Full Text] [Related]
13. Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.
Liu YZ; Jackson AP; Cosgrove SD
Osteoarthritis Cartilage; 2009 Oct; 17(10):1333-40. PubMed ID: 19447216
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
Ryu K; Iriuchishima T; Oshida M; Kato Y; Saito A; Imada M; Aizawa S; Tokuhashi Y; Ryu J
Osteoarthritis Cartilage; 2014 Jul; 22(7):975-9. PubMed ID: 24814686
[TBL] [Abstract][Full Text] [Related]
15. Tophaceous pseudogout (tumoral calcium pyrophosphate dihydrate crystal deposition disease).
Ishida T; Dorfman HD; Bullough PG
Hum Pathol; 1995 Jun; 26(6):587-93. PubMed ID: 7774886
[TBL] [Abstract][Full Text] [Related]
16. Calcium pyrophosphate dehydrate crystal deposition in the ligamentum flavum of the cervical spine: histopathological and immunohistochemical findings.
Mwaka ES; Yayama T; Uchida K; Kobayashi S; Kokubo Y; Nakajima H; Sato R; Orwotho NT; Baba H
Clin Exp Rheumatol; 2009; 27(3):430-8. PubMed ID: 19604435
[TBL] [Abstract][Full Text] [Related]
17. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
Pritzker KP; Cheng PT; Renlund RC
J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
[TBL] [Abstract][Full Text] [Related]
18. [Calcium pyrophosphate crystal deposition disease:report of two cases].
Jiang ZM; Zhang HZ
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):848-9. PubMed ID: 20193468
[No Abstract] [Full Text] [Related]
19. Calcium pyrophosphate dihydrate crystal deposition disease: a review of the literature and a light and electron microscopic study of a case of the temporomandibular joint with numerous intracellular crystals in the chondrocytes.
Dijkgraaf LC; Liem RS; de Bont LG; Boering G
Osteoarthritis Cartilage; 1995 Mar; 3(1):35-45. PubMed ID: 7719954
[TBL] [Abstract][Full Text] [Related]
20. An ultrastructural study of the articular cartilage in calcium pyrophosphate dihydrate (CPPD) crystal deposition disease (chondrocalcinosis articularis).
Bjelle AO; Sundström KG
Calcif Tissue Res; 1975 Nov; 19(1):63-71. PubMed ID: 172199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
